Skip to main content
. 2010 Jun 18;10:305. doi: 10.1186/1471-2407-10-305

Table 1.

Patient characteristics at enrollment.

Characteristic Number (%)
Gender
 Male 57(61.96%)
 Female 35(38.04%)
Median age at diagnosis 42 (range, 3-76)
Tumor type
 A^ 17(18.47)
 OL^ 7(7.61)
 OA 9(9.78)
 AA^ 11(11.96)
 AO^ 2(2.17)
 AOA 6(6.52)
 GBM 34(36.96)
 Other§ 6(6.52)
WHO grade
 I 3(3.26)
 II 35(38.04)
 III 20(21.74)
 IV 34(36.96)
Tumor location
 Sub 13(14.13)
 Sup 79(85.87)
 Frontal lobe 22(27.85)
 Temporal lobe 21(26.58)
 Parietal lobe 6(7.59)
 Occipital lobe 1(1.27)
 Multiple lobes 23(29.11)
 Other 6(7.60)
Tumor hemisphere
 Left 32(40.50)
 Right 44(55.70)
 Both 3(3.80)
KPS
 100 4(4.3)
 90 40(43.5)
 80 20(21.7)
 70 7(7.6)
 60 5(5.4)
 50 6(6.5)
 <50 2(2.2)
 Unknown 8(8.7)
Cognitive function
 Normal 71(77.17)
 Abnormal 20(21.74)
 Unknown 1(1.09)

^ 1 recurrent A, 1 recurrent AA, 1 recurrent AO, 1 recurrent OL.

* 6 recurrent GBM from de novo GBM, 2 secondary GBM.

§1 gangliocytoma WHO grade I, 1 choroid plexus papilloma WHO grade I, 1 anaplastic papillary glioneuronal tumor WHO grade III, 2 ependymoma WHO grade II, 1 recurrent pilocytic astrocytoma WHO grade I.

Abbreviations: A: astrocytoma; AA: anaplastic astrocytoma; AOA: anaplastic oligoastrocytoma; AO: anaplastic oligodendroglioma; GBM: glioblastoma; OA: oligoastrocytoma; OL: oligodendroglioma; Sub: subtentorial tumor; Sup: supratentorial tumor.